[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming

R Mattioli, A Ilari, B Colotti, L Mosca, F Fazi… - Molecular Aspects of …, 2023 - Elsevier
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …

MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis

S Shirjang, B Mansoori, S Asghari, PHG Duijf… - Free Radical Biology …, 2019 - Elsevier
To protect tissues and the organism from disease, potentially harmful cells are removed
through programmed cell death processes, including apoptosis and necroptosis. These …

miR‐193: a new weapon against cancer

M Khordadmehr, R Shahbazi… - Journal of cellular …, 2019 - Wiley Online Library
Abstract microRNAs (miRNAs) are known as a large group of short noncoding RNAs, which
structurally consist of 19–22 nucleotides in length and functionally act as one of the main …

MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells

AS Zangouei, M Alimardani, M Moghbeli - Cancer Cell International, 2021 - Springer
Background Chemotherapy is one of the most common treatment options for breast cancer
(BC) patients. However, about half of the BC patients are chemotherapeutic resistant …

Noncoding RNAs: the shot callers in tumor immune escape

L Liu, Q Wang, Z Qiu, Y Kang, J Liu, S Ning… - Signal transduction and …, 2020 - nature.com
Immunotherapy, designed to exploit the functions of the host immune system against tumors,
has shown considerable potential against several malignancies. However, the utility of …

MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1

JA Hulin, S Tommasi, D Elliot, DG Hu, BC Lewis… - Scientific reports, 2017 - nature.com
Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is responsible for
metabolism of an endogenous inhibitor of nitric oxide synthase (NOS), asymmetric …

Contribution of miRNAs in the Pathogenesis of Breast Cancer

S Ghafouri-Fard, A Khanbabapour Sasi, A Abak… - Frontiers in …, 2021 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer among females. Gene expression
profiling methods have shown the deregulation of several genes in breast cancer samples …

[HTML][HTML] Autophagy-mediating microRNAs in cancer chemoresistance

Y Jing, W Liang, J Liu, L Zhang, J Wei, J Yang… - Cell biology and …, 2020 - Springer
Chemoresistance is a complex phenomenon responsible for failure in response to
chemotherapy agents and more than 90% of deaths in cancer patients. MicroRNAs …

MicroRNAs as a clue to overcome breast cancer treatment resistance

I Garrido-Cano, B Pattanayak, A Adam-Artigues… - Cancer and Metastasis …, 2022 - Springer
Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in
diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain …

The role of microRNAs on doxorubicin drug resistance in breast cancer

K Jamialahmadi, F Zahedipour… - Journal of Pharmacy and …, 2021 - academic.oup.com
Objectives Resistance to chemotherapeutic drugs is a serious challenge for effective therapy
of cancers. Doxorubicin is a drug which is typically used for breast cancer treatment. Several …